We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies.
NOVATEC IMMUNDIAGNOSTICA GMBH is a leading diagnostics company specialised in the development and manufacture of ELISA products for human and veterinary infectious disease testing (bacterial, viral and parasitic diseases). The product range also includes Real-time PCR and Line Blots.
The GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab) is a single-use test kit intended to detect the presence of the SARS-CoV-2 virus, with self-collected nasal swab specimen from symptomatic individuals who are suspected of being infected with COVID-19. A positive result indicates SARS-CoV-2 antigens present in the specimen.
The Mplex SARS-CoV-2+, Flu A, Flu B (C1) RT-PCR assay allows to differentiate in a single reaction between Influenza A and B, and simultaneously detects two independent gene targets in SARS-CoV-2 (N-gene + RdRP-gene). It can be processed in parallel with RSV A, RSV B RT-PCR in the same plate using the same temperature profile for fast and reliable results in approximately one hour.
The SARS-CoV-2 (COVID-19) IgA ELISA is intended for the qualitative determination of IgA class antibodies against SARS-CoV-2 in human serum or plasma (citrate, heparin) to support the diagnosis of COVID-19.
The SARS-CoV-2 (COVID-19) IgG ELISA is intended for the qualitative determination of IgG class antibodies against SARS-CoV-2 in human serum or plasma (citrate, heparin) to support the diagnosis of COVID-19.
The SARS-CoV-2 (COVID-19) IgM ELISA is intended for the qualitative determination of IgM class antibodies against SARS-CoV-2 in human serum or plasma (citrate, heparin) to support the diagnosis of COVID-19.
NovaLisa Chlamydia pneumoniae IgA is an enzyme-linked immunosorbent assay intended for the qualitative detection of IgA antibodies against Chlamydia pneumoniae in human serum or plasma (citrate, heparin).
NovaLisa Bordetella pertussis toxin IgG is an enzyme-linked immunosorbent assay intended for the quantitative detection of IgG antibodies against Bordetella pertussis toxin (PT) in human serum or plasma (citrate, heparin).
NovaLisa Aspergillus fumigatus IgM is an enzyme-linked immunosorbent assay intended for the qualitative detection of IgM antibodies against Aspergillus fumigatus in human serum or plasma (citrate, heparin).
NovaLisa Chlamydia pneumoniae IgA is an enzyme-linked immunosorbent assay intended for the qualitative detection of IgA antibodies against Chlamydia pneumoniae in human serum or plasma (citrate, heparin).
NovaLisa Bordetella pertussis toxin IgG is an enzyme-linked immunosorbent assay intended for the quantitative detection of IgG antibodies against Bordetella pertussis toxin (PT) in human serum or plasma (citrate, heparin).
NovaLisa Aspergillus fumigatus IgM is an enzyme-linked immunosorbent assay intended for the qualitative detection of IgM antibodies against Aspergillus fumigatus in human serum or plasma (citrate, heparin).
NovaLisa Anti-TPO is an enzyme-linked immunosorbent assay intended for the quantitative detection of autoantibodies to Thyroid Peroxidase (TPO) in human serum or plasma (citrate, heparin).
The NovaLisa Influenza Virus B IgM (96 tests) - INFM0300 is an enzyme-linked immunosorbent assay intended for the qualitative detection of IgM antibodies against influenza virus B in human serum or plasma (citrate, heparin). The test comes with ready-to-use, color-coded reagents, and breakable strip plates, and adopts standardized methods suitable for automated procedures.
The NovaLisa Respiratory Syncytial Virus IgA (96 tests) - RSVA0380 is an enzyme-linked immunosorbent assay intended for the qualitative detection of IgA antibodies against respiratory syncytial virus in human serum or plasma (citrate, heparin). The test comes with ready-to-use, color-coded reagents, and breakable strip plates, and adopts standardized methods suitable for automated procedures.
The NovaLisa TSH (96 tests) - TSH1030 is an enzyme-linked immunosorbent assay intended for the quantitative detection of Thyroid-Stimulating Hormone (TSH) in human serum or plasma (citrate, heparin). The test comes with ready-to-use, color-coded reagents, and breakable strip plates, and adopts standardized methods suitable for automated procedures.
The NovaLisa Zika Virus IgG capture (96 tests) - ZVG0790 is an enzyme-linked immunosorbent assay intended for the qualitative detection of IgG antibodies against Zika virus in human serum or plasma (citrate, heparin). The test comes with ready-to-use, color-coded reagents, and breakable strip plates, and adopts standardized methods suitable for automated procedures.
The Dengue Virus IgM ELISA is intended for the qualitative determination of IgM class antibodies against Dengue Virus in human serum or plasma (citrate, heparin). It has a diagnostic sensitivity of 91.84% (95%-width of CI: 80.4% .. 97.73%) and diagnostic specificity of 96.59% (95%-width of CI: 92.73% .. 98.74%).
The Chlamydia trachomatis IgG-ELISA is intended for the qualitative determination of IgG class antibodies against Chlamydia trachomatis in human serum or plasma (citrate, heparin). It has a diagnostic sensitivity of 97.33% (95%-width of CI: 90.7% .. 99.68%) and diagnostic specificity of 95.93% (95%-width of CI: 90.77% .. 98.67%).
The Adenovirus IgG-ELISA is intended for the qualitative determination of IgG class antibodies against Adenovirus in human serum or plasma (citrate, heparin). It has a diagnostic sensitivity of 100% (95%-width of CI: 95.2% .. 100%) and diagnostic specificity of 90.91 % (95%-width of CI: 70.84% .. 98.88%).
The AIX1000 is an FDA cleared, fully automated system for nontreponemal, rapid plasma reagin (RPR) testing. It has been designed to simplify the processing, analysis, result interpretation, and archiving for RPR screens and semi-quantitative titers.
The NovaLisa Zika Virus IgM μ-capture ELISA is intended for the qualitative determination of IgM antibodies to Zika virus in human serum or plasma (citrate, heparin). The test has a diagnostic sensitivity of 100% and diagnostic specificity of 98.6%.
The NovaLisa Anti-TG ELISA is intended for the quantitative determination of autoantibodies to TG (thyroglobulin) in human serum or plasma (citrate, heparin). The test has a diagnostic sensitivity of 87.50% and diagnostic specificity of 97.14%.
The Mplex SARS-CoV-2+, Flu A, Flu B (C1) RT-PCR assay allows to differentiate in a single reaction between Influenza A and B, and simultaneously detects two independent gene targets in SARS-CoV-2 (N-gene + RdRP-gene). It can be processed in parallel with RSV A, RSV B RT-PCR in the same plate using the same temperature profile for fast and reliable results in approximately one hour.
The GSD NovaGen SARS-CoV-2 Ag Rapid Test (Nasal Swab) is a single-use test kit intended to detect the presence of the SARS-CoV-2 virus, with self-collected nasal swab specimen from symptomatic individuals who are suspected of being infected with COVID-19. A positive result indicates SARS-CoV-2 antigens present in the specimen.
The SARS-CoV-2 (COVID-19) IgM ELISA is intended for the qualitative determination of IgM class antibodies against SARS-CoV-2 in human serum or plasma (citrate, heparin) to support the diagnosis of COVID-19.
The SARS-CoV-2 (COVID-19) IgG ELISA is intended for the qualitative determination of IgG class antibodies against SARS-CoV-2 in human serum or plasma (citrate, heparin) to support the diagnosis of COVID-19.
The SARS-CoV-2 (COVID-19) IgA ELISA is intended for the qualitative determination of IgA class antibodies against SARS-CoV-2 in human serum or plasma (citrate, heparin) to support the diagnosis of COVID-19.